tiprankstipranks

Kamil Ali-Jackson Insider Profile

4 Followers
Kamil Ali-Jackson, CLO at Aclaris Therapeutics, holds 68.75K shares in Rigel (Ticker: RIGL), holds 160.21K shares in Aclaris Therapeutics (Ticker: ACRS), holds 11.76K shares in PDS Biotechnology (Ticker: PDSB).
tipranks
Kamil Ali-Jackson

Kamil Ali-Jackson
Aclaris Therapeutics (ACRS)
CLO

Not Ranked
Kamil Ali-Jackson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
74.59%
20.70%
4.70%
A breakdown of Kamil Ali-Jackson's holdings

Insider Roles

Rigel
(RIGL)
Director
Aclaris Therapeutics
(ACRS)
CLO
PDS Biotechnology
(PDSB)
Director
Roles that Kamil Ali-Jackson holds in companies

Most Profitable Insider Trade

Stock:
PDS Biotechnology
(PDSB)
Rating:Informative Buy
Date:Jun 17, 2021 - Jun 17, 2022
Return:-66.30%
The most profitable trade made by Kamil Ali-Jackson

Kamil Ali-Jackson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aclaris Therapeutics
Jan 05, 2022
CLO
Uninformative Buy
664.11K
$214.69K
PDS Biotechnology
Jun 17, 2021
Director
Informative Buy
99.99K
$48.76K
Rigel
May 29, 2024
Director
Uninformative Buy
$773.44K
List of latest transactions for each holding click on a transaction to see Kamil Ali-Jackson's performance on stock

Kamil Ali-Jackson insider profile FAQ

What is the percentage of profitable transactions made by Kamil Ali-Jackson?
The percentage of profitable transactions made by Kamil Ali-Jackson is ―.
    What is the average return per transaction made by Kamil Ali-Jackson?
    The average return per transaction made by Kamil Ali-Jackson is ―.
      What stocks does Kamil Ali-Jackson hold?
      Kamil Ali-Jackson holds: ACRS, PDSB, RIGL stocks.
        What was Kamil Ali-Jackson’s latest transaction?
        Kamil Ali-Jackson latest transaction was an Uninformative Buy of ―.
          What was Kamil Ali-Jackson's most profitable transaction?
          Kamil Ali-Jackson’s most profitable transaction was an Informative Buy of PDSB stock on June 17, 2021. The return on the trade was -66.30%.
            What is Kamil Ali-Jackson's role in Aclaris Therapeutics?
            Kamil Ali-Jackson's role in Aclaris Therapeutics is CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.